Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Finance Today.
Press releases published on May 9, 2025
Spectral Medical Announces First Quarter and Provides Corporate Update
GlobeNewswire
·
May 9, 2025
Tigris Trial Enrollment completed Topline results expected to be released in August 2025 Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Spectral Medical …
Escuela de Alergia de Hong Kong 2025 de la EAACI: un hito en la educación mundial sobre alergias
GlobeNewswire
·
May 9, 2025
ZÚRICH, May 09, 2025 (GLOBE NEWSWIRE) -- La Academia Europea de Alergia e Inmunología Clínica (EAACI, por sus siglas en inglés), en colaboración con el Instituto de Alergia de Hong Kong (HKIA), se enorgullece de anunciar la inauguración de la Escuela de …
בית הספר לאלרגיה EAACI הונג קונג 2025: ציון דרך בטיפול החדשני העולמי באלרגיה
GlobeNewswire
·
May 9, 2025
ציריך, May 09, 2025 (GLOBE NEWSWIRE) -- האקדמיה האירופית לאלרגיה ואימונולוגיה קלינית (EAACI), בשותפות עם המכון לאלרגיה של הונג קונג (HKIA), גאה להכריז על בית הספר לאלרגיה של EAACI בהונג קונג. ציון דרך משמעותי זה יתרחש בהונג קונג - עיר העולם של אסיה - מרכז …
Sekolah Alergi EAACI Hong Kong 2025: Tonggak Sejarah dalam Pendidikan Alergi Global
GlobeNewswire
·
May 9, 2025
ZURICH, May 09, 2025 (GLOBE NEWSWIRE) -- Akademi Alergi dan Imunologi Klinis Eropa (European Academy of Allergy and Clinical Immunology, EAACI), melalui kemitraan dengan Institut Alergi Hong Kong (Hong Kong Institute of Allergy, HKIA), dengan bangga …
2025年度EAACI香港アレルギースクール (EAACI Hong Kong Allergy School 2025)：世界のアレルギー教育におけるランドマーク
GlobeNewswire
·
May 9, 2025
チューリッヒ発, May 09, 2025 (GLOBE NEWSWIRE) -- 欧州アレルギー・臨床免疫学会 (European Academy of Allergy …
EAACI 홍콩 알레르기 스쿨 2025, 글로벌 알레르기 교육의 랜드마크로 시선 모아
GlobeNewswire
·
May 9, 2025
취리히, May 09, 2025 (GLOBE NEWSWIRE) -- 유럽 알레르기 임상 면역학회(EAACI)가 홍콩 알레르기 연구소(HKIA)와 협력하여 제1회 EAACI 홍콩 알레르기 스쿨 (EAACI Hong Kong Allergy School)을 개최하게 된다고 발표했다. 이 중요한 이정표는 동양과 서양이 만나고, 혁신과 전통이 어우러지며, 글로벌 마인드가 모이게 되는 역동적인 허브인 아시아의 세계 도시 홍콩에서 진행될 예정이다. “동양과 서양의 …
EAACI Hong Kong Allergy School 2025: Mercu Tanda dalam Pendidikan Alergi Global
GlobeNewswire
·
May 9, 2025
ZURICH, May 09, 2025 (GLOBE NEWSWIRE) -- European Academy of Allergy …
EAACI Hong Kong Allergy School 2025: Ein Meilenstein in der globalen Allergieaufklärung
GlobeNewswire
·
May 9, 2025
ZÜRICH, May 09, 2025 (GLOBE NEWSWIRE) -- Die European Academy of Allergy …
EAACI Hong Kong Allergy School 2025: Um Marco na Educação Global sobre Alergias
GlobeNewswire
·
May 9, 2025
ZURIQUE, May 09, 2025 (GLOBE NEWSWIRE) -- A Academia Europeia de Alergia e Imunologia Clínica (EAACI), em parceria com o Instituto de Alergia de Hong Kong (HKIA), tem a alegria de anunciar a primeira edição da EAACI Hong Kong Allergy School. Este …
École d’allergologie de l’EAACI à Hong Kong 2025 : un modèle pour l’enseignement mondial de l’allergologie
GlobeNewswire
·
May 9, 2025
ZURICH, 09 mai 2025 (GLOBE NEWSWIRE) -- L’Académie européenne d’allergologie et d’immunologie clinique (The European Academy of Allergy …
2025 年 EAACI 香港过敏学校：全球过敏教育的里程碑
GlobeNewswire
·
May 9, 2025
苏黎世, May 09, 2025 (GLOBE NEWSWIRE) -- 欧洲过敏和临床免疫学学会（European Academy of Allergy …
EAACI 香港過敏學校 2025：全球過敏教育的里程碑
GlobeNewswire
·
May 9, 2025
蘇黎世, May 09, 2025 (GLOBE NEWSWIRE) -- 歐洲過敏及臨床免疫學會 (EAACI) 與香港過敏科醫學會 (HKIA) 攜手合作，隆重宣布首屆 EAACI 香港過敏學校開幕。 這項重要的里程碑活動將於香港這個充滿活力的亞洲國際都會展開，東方與西方在此交匯，創新與傳統碰撞，全球思潮匯聚一堂。 2025 年過敏學校以「東方遇見西方」為主題，朝着推動過敏及臨床免疫學跨洲合作邁出了大膽的一步。 …
EAACI Hong Kong Allergy School 2025: ความสำเร็จครั้งสำคัญด้านการศึกษาโรคภูมิแพ้ระดับโลก
GlobeNewswire
·
May 9, 2025
ซูริก, May 09, 2025 (GLOBE NEWSWIRE) -- European Academy of Allergy …
Anika Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
First Quarter 2025 Commercial Channel revenue up 18% Integrity™ Implant System continues sequential growth and is on pace to more than double procedures in 2025 Key regulatory and clinical milestones achieved for Hyalofast®, Cingal®, and Integrity Updating …
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
GlobeNewswire
·
May 9, 2025
~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related serious adverse events ~ ~ Held Type B FDA meetings in …
Top Tribal Loans with Guaranteed Approval for Bad Credit – IOnline Payday Loans
GlobeNewswire
·
May 9, 2025
SHERIDAN, Wyo., May 09, 2025 (GLOBE NEWSWIRE) -- If your credit score isn’t perfect, the search for financial assistance can seem to be very frustrating— but it doesn’t have to be. Tribal loans direct lenders guaranteed approval have proven to be a …
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33 …
Onex Reports First Quarter 2025 Results
GlobeNewswire
·
May 9, 2025
All amounts in U.S. dollars unless otherwise stated TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) today announced its financial results for the first quarter ended March 31, 2025. “Onex continues to make progress and is benefitting …
Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 9, 2025
Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) with data expected in 4Q25 KT-579 (IRF5) new …
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 9, 2025
Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for mid-2025 development candidate nomination and IND filing …